GAMMA Investing’s LifeMD LFMD Stock Holding History

GAMMA Investing’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.43K	Buy	1,184 +500	+73%	+$1.8K	﹤0.01%	3793
2026 Q2	$2.83K	Hold	684	–	–	﹤0.01%	3660
2026 Q1	$2.47K	Buy	+684	New	+$2.37K	﹤0.01%	3595
2025 Q4	–	Sell	-1,248	Closed	-$8.47K	–	4111
2025 Q3	$8.47K	Sell	1,248 -88	-7%	-$727	﹤0.01%	2958
2025 Q2	$18.2K	Buy	1,336 +150	+13%	+$1.42K	﹤0.01%	2508
2025 Q1	$6.45K	Buy	+1,186	New	+$6.73K	﹤0.01%	2966

Other funds holding LFMD

Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's LFMD Position: Q3 2026 in Review

GAMMA Investing increased its LifeMD (LFMD) stake by 73% in Q3 2026, buying an estimated $1.8K and bringing the position to 1,184 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3793.

GAMMA Investing first reported a position in LFMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $18.2K in Q2 2025. 3 funds tracked by Wall St. Rank hold LFMD as of Q3 2026.

GAMMA Investing held 1,184 shares of LifeMD worth $3.43K as of Q3 2026.
GAMMA Investing bought 500 LifeMD shares in Q3 2026, an estimated $1.8K.
LifeMD made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3793 holding.
GAMMA Investing first reported a position in LifeMD in Q1 2025 and has held it in 6 quarters since.
GAMMA Investing's LifeMD position peaked at $18.2K in Q2 2025.
3 funds tracked by Wall St. Rank held LifeMD as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.